Caption Management, LLC Clearside Biomedical, Inc. Transaction History
Caption Management, LLC
- $9.8 Billion
- Q4 2024
A detailed history of Caption Management, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 15,000 shares of CLSD stock, worth $15,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$15,000% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CLSD
# of Institutions
50Shares Held
11.6MCall Options Held
24KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA2.81MShares$2.81 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$2.2 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.93MShares$1.93 Million0.03% of portfolio
-
Black Rock Inc. New York, NY798KShares$798,1370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA764KShares$764,0580.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $60.2M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...